nach oben

Investigational New Drugs

Erschienen in:

29.11.2018 | PRECLINICAL STUDIES

A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells

verfasst von: Wanbin Yang, Xiuli Gong, Xiulian Wang, Chao Huang

Erschienen in: Investigational New Drugs | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Summary

Purpose Transdifferentiation exists within stromal cells in the tumour microenvironment. Transforming growth factor-β (TGF-β) secreted by tumour-associated fibroblasts (TAFs) affects the differentiation states of epithelial cells, including epithelial-mesenchymal transition (EMT). Evodiamine, a natural drug, can regulate differentiation. However, the specific effects and relative mechanisms of evodiamine remain unknown. Design We used four models to observe the influence of TAF-like CCD-18Co cells on the colon epithelial cell line HCoEpiC: the 3D- and 2D-mono-culture system, Transwell and direct co-culture model. Additionally, we established conditioned medium from CCD-18Co cells. The TGF-β pathway inhibitor LY364947 and evodiamine were added. Morphological changes and classical EMT markers were observed and detected using phase contrast microscopy and immunofluorescence. Cell migration was measured by the wound-healing assay. Western blotting was performed to detect the TGF-β/Smad signalling pathway. Results CCD-18Co cells induced EMT-like changes in the 2D- and 3D-cultured epithelial cell line HCoEpiC, accompanied by high expression of ZEB1 and Snail and the enhancement of migration. Moreover, CCD-18Co-derived conditioned medium caused dysfunction of TGF-β/Smad signalling in EMT. Evodiamine inhibited these EMT-like HCoEpiC and their migration. Additionally, evodiamine down-regulated the expression of ZEB1/Snail and up-regulated the expression of phosphorylated Smad2/3 (pSmad2/3). Evodiamine also increased the ratios of pSmad2/Smad2 and pSmad3/Smad3. Conclusion Based on our observations, evodiamine can reverse the TAF-induced EMT-like phenotype in colon epithelial cells, which may be associated with its mediation of phosphorylated Smad2 and Smad3 expression.

Servais C, Erez N (2013) From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation. J Pathol 229:198–207CrossRefPubMed

Glentis A, Oertle P, Mariani P, Chikina A, El Marjou F, Attieh Y et al (2017) Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane. Nat Commun 8(1):924CrossRefPubMedPubMedCentral

Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, onder TT, Wang ZC, Richardson AL, Weinberg RA, Orimo A (2010) Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A 107:20009–20014CrossRefPubMedPubMedCentral

Achyut BR, Yang L (2011) Transforming growth factor-β in the gastrointestinal and hepatic tumor microenvironment. Gastroenterology 141(4):1167–1178CrossRefPubMedPubMedCentral

Neuzillet C, Tijeras-Raballand A, Cohen R, Cros J, Faivre S, Raymond E, de Gramont A (2015) Targeting the TGFβ pathway for cancer therapy. Pharmacol Ther 147:22–31CrossRef

Mukaida N, Sasaki S (2016) Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol 22(23):5301–5316CrossRefPubMedPubMedCentral

Guarino M, Tosoni A, Nebuloni M (2009) Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition. Hum Pathol 40:1365–1376CrossRefPubMed

Yu HI, Chou HC, Su YC, Lin LH, Lu CH, Chuang HH, Tsai YT, Liao EC, Wei YS, Yang YT, Lee YR, Chan HL (2018) Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells. J Pharm Biomed Anal 160:344–350CrossRefPubMed

Zhou Y, Hu J (2018) Evodiamine induces apoptosis, G2/M cell cycle arrest, and inhibition of cell migration and invasion in human osteosarcoma cells via Raf/MEK/ERK Signalling pathway. Med Sci Monit 24:5874–5880CrossRefPubMedPubMedCentral

10.

Huang C, Wen B (2016) Phenotype transformation of immortalized NCM460 colon epithelial cell line by TGF-β1 is associated with chromosome instability. Mol Biol Rep 43:1069–1078CrossRefPubMed

11.

Bauer M, Su G, Casper C, He R, Rehrauer W, Friedl A (2010) Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 29(12):1732–1740CrossRefPubMedPubMedCentral

12.

Navab R, Strumpf D, Bandarchi B, Zhu CQ, Pintilie M, Ramnarine VR, Ibrahimov E, Radulovich N, Leung L, Barczyk M, Panchal D, To C, Yun JJ, der S, Shepherd FA, Jurisica I, Tsao MS (2011) Prognostic gene-expression signature of carcinoma-associated fibroblasts in non-small cell lung cancer. Proc Natl Acad Sci U S A 108(17):7160–7165CrossRefPubMedPubMedCentral

13.

De Wever O, Demetter P, Mareel M, Bracke M (2008) Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123(10):2229–2238CrossRefPubMed

14.

Calon A, Tauriello DV, Batlle E (2014) TGF-beta in CAF-mediated tumor growth and metastasis. Semin Cancer Biol 25:15–22CrossRefPubMed

15.

Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD (2018) Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T cells to protect tumour cells. Nat Commun 9(1):948CrossRefPubMedPubMedCentral

16.

Giménez-Bastida JA, Surma M, Zieliński H (2015) In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co. Toxicol in Vitro 29(7):1683–1691CrossRefPubMed

17.

Pereira C, Araújo F, Barrias CC, Granja PL, Sarmento B (2015) Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies. Biomaterials 56:36–45CrossRefPubMed

18.

Chen Q, Liu G, Liu S, Su H, Wang Y, Li J, Luo C (2018) Remodeling the tumor microenvironment with emerging Nanotherapeutics. Trends Pharmacol Sci 39(1):59–74CrossRefPubMed

19.

Papageorgis P (2015) TGFβ signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis. J Oncol 2015:587193CrossRefPubMedPubMedCentral

20.

Fearon ER (2011) Molecular genetics of colorectal cancer. Annu Rev Pathol 6:479–507CrossRef

21.

Lyu G, Guan Y, Zhang C, Zong L, Sun L, Huang X, Huang L, Zhang L, Tian XL, Zhou Z, Tao W (2018) TGF-β signaling alters H4K20me3 status via miR-29 and contributes to cellular senescence and cardiac aging. Nat Commun 9(1):2560CrossRefPubMedPubMedCentral

22.

Wei J, Li Z, Yuan F (2014) Evodiamine might inhibit TGF-beta1-induced epithelial-mesenchymal transition in NRK52E cells via Smad and PPAR-gamma pathway. Cell Biol Int 38(7):875–880CrossRefPubMed

23.

Massagué J (2008) TGFbeta in Cancer. Cell 134(2):215–230CrossRefPubMedPubMedCentral

24.

Peng X, Zhang Q, Zeng Y, Li J, Wang L, Ai P (2015) Evodiamine inhibits the migration and invasion of nasopharyngeal carcinoma cells in vitro via repressing MMP-2 expression. Cancer Chemother Pharmacol 76(6):1173–1184CrossRefPubMed

25.

Wen Z, Feng S, Wei L, Wang Z, Hong D, Wang Q (2015) Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells. Int J Mol Med 36(6):1657–1663CrossRefPubMed

26.

David CJ, Huang YH, Chen M, Su J, Zou Y, Bardeesy N, Iacobuzio-Donahue CA, Massagué J (2016) TGF-β tumor suppression through a lethal EMT. Cell 164(5):1015–1030CrossRefPubMedPubMedCentral

27.

Vera-Ramirez L, Sanchez-Rovira P, Ramirez-Tortosa CL, Quiles JL, Ramirez-Tortosa MC, Alvarez JC, Fernandez-Navarro M, Lorente JA (2010) Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: latest advances towards an integrated approach. Cancer Treat Rev 36:477–484CrossRefPubMed

28.

Bussard KM, Mutkus L, Stumpf K, Gomez-Manzano C, Marini FC (2016) Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res 18(1):84CrossRefPubMedPubMedCentral

29.

Klingberg F, Hinz B, White ES (2013) The myofibroblast matrix: implications for tissue repair and fibrosis. J Pathol 229:298–309CrossRefPubMedPubMedCentral

30.

Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835–870CrossRefPubMed

31.

Giménez-Bastida JA, Laparra-Llopis JM, Baczek N, Zielinski H (2018) Buckwheat and buckwheat enriched products exert an anti-inflammatory effect on the myofibroblasts of colon CCD-18Co. Food Funct 9(6):3387–3397CrossRefPubMed

32.

McDonald LT, LaRue AC (2012) Hematopoietic stem cell derived carcinoma-associated fibroblasts: a novel origin. Int J Clin Exp Pathol 5(9):863–873PubMedPubMedCentral

33.

Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J, Li Q (2015) Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated snail/E-cadherin expression. BMC Cancer 15:97CrossRefPubMedPubMedCentral

34.

Dong F, Liu T, Jin H, Wang W (2018) Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways. Can J Physiol Pharmacol 96(1):1–7CrossRefPubMed

35.

Ioannou M, Kouvaras E, Papamichali R, Samara M, Chiotoglou I, Koukoulis G (2018) Smad4 and epithelial-mesenchymal transition proteins in colorectal carcinoma: an immunohistochemical study. J Mol Histol 49(3):235–244CrossRefPubMed

36.

Dong Z, Tai W, Lei W, Wang Y, Li Z, Zhang T (2016) IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells. BMC Cell Biol 17:7CrossRefPubMedPubMedCentral

37.

Su T, Yang X, Deng JH, Huang QJ, Huang SC, Zhang YM, Zheng HM, Wang Y, Lu LL, Liu ZQ (2018) Evodiamine, a novel NOTCH3 methylation stimulator, significantly suppresses lung carcinogenesis in vitro and in vivo. Front Pharmacol 9:434. https://doi.org/10.3389/fphar.2018.00434 CrossRefPubMedPubMedCentral

38.

Yao X, Yu T, Zhao C, Li Y, Peng Y, Xi F, Yang G (2018) Evodiamine promotes differentiation and inhibits proliferation of C2C12 muscle cells. Int J Mol Med 41(3):1627–1634PubMed

Titel: A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells
verfasst von: Wanbin Yang
Xiuli Gong
Xiulian Wang
Chao Huang
Publikationsdatum: 29.11.2018
Verlag: Springer US
Erschienen in: Investigational New Drugs / Ausgabe 5/2019
Print ISSN: 0167-6997
Elektronische ISSN: 1573-0646
DOI: https://doi.org/10.1007/s10637-018-0702-x

Neu im Fachgebiet Onkologie

17.04.2024 | Mammakarzinom | Nachrichten

Springer Medizin

A mediator of phosphorylated Smad2/3, evodiamine, in the reversion of TAF-induced EMT in normal colonic epithelial cells

Summary

Neu im Fachgebiet Onkologie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Update Onkologie

Springer Medizin

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2019

A novel tetravalent bispecific antibody targeting programmed death 1 and tyrosine-protein kinase Met for treatment of gastric cancer

The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States

MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells

A novel humanized anti-PD-1 monoclonal antibody potentiates therapy in oral squamous cell carcinoma

Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo

MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer

Neu im Fachgebiet Onkologie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Manche Gestagene können das Risiko für Meningeome erhöhen

Einladung zum PSA-Screening senkt die Krebssterblichkeit

Chemotherapie mit Hindernissen

Update Onkologie